NexImmune Inc. (NEXI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NexImmune Inc.

    OTC: NEXI · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Apr 04, 2025, 11:37 AM

    NexImmune Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 1.02M 1.5M 870.28K
    Gross Profit
    		 -1.02M -1.5M -870.28K
    Operating Income
    		 -29.19M -63.08M -53.26M
    Interest Income
    		 698.39M 664.37K 52.51K
    Pretax Income
    		 -32.34M -62.51M -50.9M
    Net Income
    		 -32.34M 514.18M -51.75M
    Selling & General & Admin
    		 9.91M 15.93M 15.8M
    Research & Development
    		 18.26M 47.15M 37.46M
    Other Expenses
    		 n/a -87.68K -61.41K
    Operating Expenses
    		 28.17M 63.08M 53.26M
    Interest Expense
    		 n/a n/a 905.33K
    Selling & Marketing Expenses
    		 -12.99B n/a n/a
    Cost & Expenses
    		 29.19M 63.08M 53.26M
    Income Tax Expense
    		 -2 -576.69M 843.92K
    Shares Outstanding (Basic)
    		 1.05M 962.36K 913.16K
    Shares Outstanding (Diluted)
    		 1.05M 962.36K 913.16K
    EPS (Basic)
    		 -30.82 534.29 -56.67
    EPS (Diluted)
    		 -30.82 534.29 -56.67
    EBITDA
    		 -28.17M -61.59M -52.39M
    EBIT
    		 n/a -639.2M -50M
    Depreciation & Amortization
    		 1.02M 1.5M 870.28K

    Add to Watchlist